I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Krytska, Kateryna
21
results:
Search for persons
X
Format
Online (21)
Mediatypes
Articles (Online) (6)
OpenAccess-fulltext (15)
Sorted by: Relevance
Sorted by: Year
?
1
Identification and characterization of chemotherapy resista..:
Grossmann, Liron D.
;
Chen, Chia-Hui
;
Uzun, Yasin
...
Cancer Discovery. , 2024
Link:
https://doi.org/10.1158/..
?
2
Circulating tumor DNA reveals mechanisms of lorlatinib resi..:
Berko, Esther R.
;
Witek, Gabriela M.
;
Matkar, Smita
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
3
Lorlatinib with or without chemotherapy in ALK-driven refra..:
Goldsmith, Kelly C.
;
Park, Julie R.
;
Kayser, Kimberly
...
Nature Medicine. 29 (2023) 5 - p. 1092-1102 , 2023
Link:
https://doi.org/10.1038/..
?
4
Evaluation of the DLL3-targeting Antibody–Drug Conjugate Ro..:
Krytska, Kateryna
;
Casey, Colleen E.
;
Pogoriler, Jennifer
...
Cancer Research Communications. 2 (2022) 7 - p. 616-623 , 2022
Link:
https://doi.org/10.1158/..
?
5
Exploitation of the Apoptosis-Primed State of MYCN-Amplifie..:
Ham, Jungoh
;
Costa, Carlotta
;
Sano, Renata
...
Cancer Cell. 29 (2016) 2 - p. 159-172 , 2016
Link:
https://doi.org/10.1016/..
?
6
Surfactant protein D inhibits TNF-α production by macrophag..:
Hortobágyi, László
;
Kierstein, Sonja
;
Krytska, Kateryna
...
Journal of Allergy and Clinical Immunology. 122 (2008) 3 - p. 521-528 , 2008
Link:
https://doi.org/10.1016/..
?
7
Circulating tumor DNA reveals mechanisms of lorlatinib resi..:
Berko, Esther R
;
Witek, Gabriela M
;
Matkar, Smita
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163008/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
Lorlatinib with or without chemotherapy in ALK-driven refra..:
Goldsmith, Kelly C
;
Park, Julie R
;
Kayser, Kimberly
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202811/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
Evaluation of the DLL3-targeting antibody-drug conjugate ro..:
Krytska, Kateryna
;
Casey, Colleen E
;
Pogoriler, Jennifer
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648412/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
10
Venetoclax-based rational combinations are effective in mod..:
Dalton, Krista M
;
Krytska, Kateryna
;
Lochmann, Timothy L
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350345/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
11
The B7-H3-targeting antibody-drug conjugate m276-SL-PBD is ..:
Kendsersky, Nathan M
;
Lindsay, Jarrett
;
Kolb, E. Anders
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127361/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
12
Genomic Profiling of Childhood Tumor Patient-Derived Xenogr..:
Rokita, Jo Lynne
;
Rathi, Komal S
;
Cardenas, Maria F
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880934/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
13
Genomic Profiling of Childhood Tumor Patient-Derived Xenogr..:
Rokita, Jo Lynne
;
Rathi, Komal S
;
Cardenas, Maria F
...
qt1s95g2zj. , 2019
Link:
https://escholarship.org..
?
14
Broad spectrum activity of the checkpoint kinase 1 inhibito..:
Lowery, Caitlin D
;
Dowless, Michele
;
Renschler, Matthew
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445779/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
15
Dual ALK and CDK4/6 inhibition demonstrates synergy against..:
Wood, Andrew C
;
Krytska, Kateryna
;
Ryles, Hannah
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457336/. , 2016
Link:
http://www.ncbi.nlm.nih...
1-15
